Molecular Partners

About:

Molecular Partners is a clinical-stage biopharmaceutical company.

Website: https://www.molecularpartners.com

Top Investors: Novartis, Biotechnology Value Fund, Index Ventures, Endeavour Vision, Johnson & Johnson Development Corporation

Description:

Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. They are developing a powerful new class of potent, specific and versatile small protein therapies called DARPin® therapeutics.

Total Funding Amount:

$209M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Zürich, Zurich, Switzerland

Founded Date:

2004-01-01

Contact Email:

info(AT)molecularpartners.com

Founders:

Michael Tobias Stumpp

Number of Employees:

51-100

Last Funding Date:

2024-10-25

IPO Status:

Public

Industries: